David Seiffge
@DavidSeiffge
Followers
1K
Following
4K
Media
77
Statuses
2K
Vascular neurologist at Inselspital Bern🇨🇭
Joined May 2022
RT @TECNO_Trial: 🚨 TECNO trial update 🚨 131 patients enrolled! Only 25 more to hit our target of 156 - the final countdown is on 🏁 We since….
0
11
0
RT @DOIT_trial: 📢Exciting news📢.28 trial sites in Germany, Spain, the Netherlands, and Belgium have received regulatory approval through CT….
0
8
0
RT @WorldStrokeOrg: #WSC2025 Program Highlights✨ . You will learn about:.- Risk of ischemic stroke in AF patients .- Residual risk of recur….
0
4
0
RT @touchNEUROLOGY: 🧠 Introducing Dr Björn Logi Thorarinsson as a touchNEUROLOGY Future Leader 2025, in collaboration with the @ESOstroke….
0
2
0
RT @StrokeAHA_ASA: 🌟 @ELAN_Trial subanalysis shows that prior reperfusion strategy does not modify outcome in early vs late start of antico….
0
9
0
RT @adnan_mujanovic: @MASStroke is not just another MSc program. It's a unique platform that will guide you to define the future of stroke….
0
2
0
RT @AshuPJadhav: Posterior reversible encephalopathy syndrome: evolving insights in diagnosis, management, and outcomes - The Lancet Neurol….
thelancet.com
Posterior reversible encephalopathy syndrome (PRES) is a clinicoradiological syndrome characterised by acute or subacute neurological symptoms—including encephalopathy, seizures, headache, and visual...
0
20
0
RT @DanielWalshFRCS: Outcomes After Reversible Cerebral Vasoconstriction Syndrome With Convexity Subarachnoid Hemorrhage | Neurology https:….
neurology.org
Background and ObjectivesThe most common cause of convexity subarachnoid hemorrhage (cSAH) in younger patients (younger than 60 years) is reversible cerebral vasoconstriction syndrome (RCVS)....
0
6
0
RT @FishingNeurons: Many thanks for the opportunity to discuss the CATALYST meta-analysis and our ongoing trials (ELAPSE and DO IT). @BoNo….
0
18
0
RT @GreenJournal: Neurology Podcast: Dr. Dan Ackerman and Dr. Urs Fischer discuss the optimal timing of anticoagulation after ischemic #str….
0
5
0
RT @MicieliA_MD: Code stroke🚑. Patients presents 2 hours from onset of mild dysarthria, left facial weakness (and resolved L sided weakness….
0
25
0
RT @GreenJournal: This meta-analysis indicates that switching to warfarin after a #stroke while on direct oral anticoagulants (DOACs) seems….
0
16
0
RT @mxhawkes: Check out our latest article exploring the advances in posterior reversible encephalopathy syndrome: pathophysiology, diagnos….
0
41
0
RT @ShadiYaghi2: Meet us at #WSC25 in Barcelona in October & attend a terrific program of cutting edge research. Also find out the final re….
0
8
0
RT @StrokeBern: Registration for the #Stroke WinterSchool 2026 is open! 🧠❄️. Join us @StrokeBern to connect, learn, and exchange on acute s….
0
20
0
RT @StrokeAHA_ASA: #STROKE: In a multicenter target trial analysis of patients with recent DOAC intake, IVT was linked to better outcomes a….
0
19
0
Thanks @GhannamMalik for your contribution! That’s a big team effort! @TotoMynell @StrokeBern @StrokeAHA_ASA @WorldStrokeEd.
I’m glad to be part of such a valuable analysis that contributes to the literature on the safety of off-label IVT use in patients taking DOACs. @MeinelThom63570 @DavidSeiffge @AHAScience.
0
2
9
RT @Morin_Beyeler: ❓Should Perfusion-weighted Imaging (PWI) be part of the acute TIA workup❓. 💡Our new study demonstrates a higher stroke r….
0
13
0